4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-007856
EXEC. VP AND CLO sold 75,420 shares at an average $53.08 ($4,003,305)
- EXEC. VP AND CLO acquired 75,420 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Option exercise 10b5-1 | +45,392 | $33.02 | $1,498,844 | 149,293 | D: show line 1 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Sale 10b5-1 | −45,392 | $53.15 | $2,412,585 | 103,901 | D: show line 2 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Option exercise 10b5-1 | +11,398 | $33.02 | $376,362 | 115,299 | D: show line 3 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Sale 10b5-1 | −11,398 | $53.12 | $605,462 | 103,901 | D: show line 4 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Option exercise 10b5-1 | +11,249 | $25.69 | $288,987 | 115,150 | D: show line 5 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Sale 10b5-1 | −3,487 | $52.24 | $182,161 | 111,663 | D: show line 6 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Sale 10b5-1 | −7,762 | $53.05 | $411,774 | 103,901 | D: show line 7 in the form |
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-11 | Option exercise 10b5-1 | +5,662 | $33.02 | $186,959 | 109,563 | D: show line 8 in the form |
| Open-market sales · 75,420 sh · avg $53.08 · $4,003,305 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,392 | 18,788 | D: show line 12 in the form | |||||
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,398 | 4,114 | D: show line 13 in the form | |||||
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,249 | 33,751 | D: show line 14 in the form | |||||
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,662 | 13,126 | D: show line 15 in the form | |||||
| Boulding Mark Elliott EXEC. VP AND CLO | 2025-03-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,719 | 2,395 | D: show line 16 in the form |
Loading xslF345X05/form4-03122025_050301.xml…